SUSMED,Inc. (TYO:4263)
Japan
· Delayed Price · Currency is JPY 557.00
-3.00 (-0.54%)
May 2, 2025, 3:30 PM JST
SUSMED,Inc. Revenue
SUSMED,Inc. had revenue of 41.00M JPY in the quarter ending December 31, 2024, a decrease of -82.40%. This brings the company's revenue in the last twelve months to 150.00M, down -79.51% year-over-year. In the fiscal year ending June 30, 2024, SUSMED,Inc. had annual revenue of 342.00M, down -35.47%.
Revenue (ttm)
150.00M
Revenue Growth
-79.51%
P/S Ratio
62.43
Revenue / Employee
3.85M
Employees
39
Market Cap
9.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 342.00M | -188.00M | -35.47% |
| Jun 30, 2023 | 530.00M | 214.00M | 67.72% |
| Jun 30, 2022 | 316.00M | 201.00M | 174.78% |
| Jun 30, 2021 | 115.00M | 81.00M | 238.24% |
| Jun 30, 2020 | 34.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |